Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

WellsCare to target Middle Eastern market for its homecare laser pain treatment device

SEOUL, South Korea, July 2, 2020 /PRNewswire/ -- WellsCare, a member company of the Born2Global Centre, will be expanding its presence in theMiddle East starting in July. WellsCare has been an active member company of theBorn2Global Centre since 2019. &amp;nbsp; WellsCare recently signe...

2020-07-02 20:30 1611

HeiQ Viroblock Certified as Cosmetic Grade and Bio-based Renewable

ZURICH, July 2, 2020 /PRNewswire/ -- Textile innovator HeiQ's antiviral textile technology, HeiQ Viroblock NPJ03, has been certified as safe and sustainable as all its ingredients are cosmetic grade, bio-based, and recycled. ...

2020-07-02 17:00 2847

HeiQ Viroblock Certified as Cosmetic Grade and Bio-based Renewable

Affinity discovers potent SARS-CoV-2 antibodies

MELBOURNE, Australia, July 2, 2020 /PRNewswire/ -- Melbourne-based Affinity Biosciences Pty Ltd (Affinity), a privately held company focused on antibody discovery for cancer therapeutics, today announces the discovery of potent antibodies with therapeutic potential against COVID-19. In March, Af...

2020-07-02 12:25 4045

Affinity discovers potent SARS-CoV-2 antibodies

CF PharmTech, Inc. Closes a US $50M Series F Financing to Accelerate the Commercialization of its Inhalation Products.

SUZHOU, China, July 2, 2020 /PRNewswire/ -- CF PharmTech, Inc. ("CF PharmTech") announced today that it has raised US $50M in Series F financing following its US$90M Series E financing in January of 2020, in total, successfully completing an equity investment deal of nearly US$140M within six mon...

2020-07-02 09:00 4597

CF PharmTech, Inc. Closes a US $50M Series F Financing to Accelerate the Commercialization of its Inhalation Products.

Antengene Corporation Appoints Former BMS Senior Leader of Biostatistics Zhinuan YU as Corporate Vice President of Biometrics and Regulatory Enabling Functions

SHANGHAI and PHILADELPHIA, July 1, 2020 /PRNewswire/ --Antengene Corporation today announced its appointment of Zhinuan Yu, Ph.D., as Corporate Vice President (CVP) of Biometrics and Regulatory Enabling Functions. Zhinuan will be responsible for providing statistical leadership and strategic r...

2020-07-02 08:16 1325

Antengene Corporation Appoints Former BMS Senior Leader of Biostatistics Zhinuan YU as Corporate Vice President of Biometrics and Regulatory Enabling Functions

FibroGenesis Identifies Mechanism Responsible for Blocking COVID19-Like Lung Inflammation

Regenerative Medicine Company Advances Development of Fibroblast-Based Product as an "Off the Shelf"Cell-Treatment for Coronavirus Acute Respiratory Distress Syndrome (ARDS) HOUSTON, July 2, 2020 /PRNewswire/ -- FibroGenesis announced today identification of molecular mechanisms associated with ...

2020-07-02 03:25 1517

FibroGenesis Identifies Mechanism Responsible for Blocking COVID19-Like Lung Inflammation

Regenerative Medicine Company Advances Development of Fibroblast-Based Product as an "Off the Shelf"Cell-Treatment for Coronavirus Acute Respiratory Distress Syndrome (ARDS) HOUSTON, July 1, 2020 /PRNewswire/ -- FibroGenesis announced today identification of molecular mechanisms associated with ...

2020-07-02 03:23 1266

Polygiene is Overall Winner in Scandinavian Outdoor Group (SOG) Awards 2020

STOCKHOLM, July 1, 2020 /PRNewswire/ -- Each year a jury from the SOG reviews new products and technologies across several categories. This knowledgeable and competent jury picked Polygiene's ViralOff® as the best new technology of the year. ViralOff was also declared overall winner of 2020! "Al...

2020-07-01 23:19 1905

Transcenta Announces First Patient Dosed in Phase I Clinical Trial of Claudin18.2 Targeting Monoclonal Antibody TST001 in the US

SUZHOU, China, July 1, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announced today that the first subject has been dosed successfull...

2020-07-01 23:00 982

Hitachi and ThinkCyte announce collaboration to develop an AI-driven cell analysis and sorting system

TOKYO, July 1, 2020 /PRNewswire/ -- Hitachi, Ltd. (TSE: 6501, "Hitachi") and ThinkCyte, Inc. ("ThinkCyte") today announced that they have entered into a collaboration focused on developing an artificial intelligence (AI)-driven cell analysis and sorting system. Hitachi provides a broad range of s...

2020-07-01 22:00 6179

Coronavirus Breakthrough: New Study Highlights Senhwa Biosciences Silmitasertib as Potential Treatment for COVID-19

TAIPEI and SAN DIEGO, July 1, 2020 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on Next Generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced that its drug Silmitasertib was again identified as o...

2020-07-01 21:00 2647

A RhoVac Article is Published in the June Edition of MedNous, a Publication of Evernow Publishing Ltd

STOCKHOLM, July 1, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") is published in the June edition of MedNous, through a written commentary by CEOAnders Månsson. In order to further attract the attention of potential partners and increase their interest in RhoVac's achievements as well as plans for t...

2020-07-01 20:41 1575

NCCN: What People with Cancer and their Caregivers Need to Know about CAR T-Cell Therapy

National Comprehensive Cancer Network's new NCCN Guidelines for Patients explain how to recognize and manage immunotherapy-related toxicities, help prepare patients for lengthy treatment duration PLYMOUTH MEETING, Pa., July 1, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN...

2020-07-01 20:35 1262

Yiling Pharmaceutical Lianhua Qingwen Capsule Extends Overseas Footprint in Southeast Asia

SHIJIAZHUANG, China, July 1, 2020 /PRNewswire/ -- Following Thailand, Singapore andIndonesia, Yiling Pharmaceutical (002603.SZ), a leader in the development of traditional Chinese medicines (TCM), obtained a Certificate of Registration issued by the Drug Department ofLaos' Ministry of Health whic...

2020-07-01 20:33 8678

Thermo Fisher Scientific Launches New MAS Omni Infectious Disease Quality Controls

FREMONT, California, July 1, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific MAS Omni Infectious Disease quality control sets for monitoring serological assays for analytes such as HIV 1&2, Hepatitis B &...

2020-07-01 20:00 1660

Thermo Fisher Scientific Launches New MAS Omni Infectious Disease Quality Controls

Anti-viral and Anti-Inflammatory Response: GoldenBiotech's Antroquinonol Receives FDA Approval on COVID-19 Phase 2 Trial in USA

TAIPEI, July 1, 2020 /PRNewswire/ -- Golden Biotechnology Corp. (GoldenBiotech, 4132.TWO), a leading Taiwanese biopharmaceutical company, announced that the FDA approved its investigational new drug (IND) application for a Phase II clinical trial of Antroquinonol (Hocena®) on COVID-19 patients in...

2020-07-01 18:36 2558

Mentice Appoints Thanos Karras as Americas General Manager to Accelerate Group's Growth Strategy

GOTHENBURG, Sweden, July 1, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC) today announced the appointment ofThanos Karras as the company's new General Manager for Americas. Thanos' appointment will play a critical role in supporting Mentice's continual growth strategy and will help accelerate its l...

2020-07-01 16:52 1342

RhoVac Marketed in International Press

STOCKHOLM, July 1, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") is marketed in the latest edition of the international trade press outlet, MedNous, through a written commentary by CEOAnders Månsson. In order to further attract the attention of potential partners and increase their interest in Rh...

2020-07-01 15:49 1314

Dr. Cipto Mangunkusumo Hospital Treats Indonesia's First Patient on Varian's Halcyon System

PALO ALTO, California and SINGAPORE, July 1, 2020 /PRNewswire/ -- Dr. Cipto Mangunkusumo Hospital,Jakarta has become the first hospital in Indonesia to treat patients using Varian's Halcyon™ system. The first patient, a 14 year old female, was treated for Hodgkin lymphoma. By 2040, more than 575...

2020-07-01 14:15 7860

Schindler launches CleanMobility solutions

HONG KONG, July 1, 2020 /PRNewswire/ -- Schindler announces the launch of CleanMobility , a new range of touchless, sanitization, and physical distancing innovations that boost hygiene and safety i...

2020-07-01 11:00 3165

1 ... 655 656 657658659 660 661 ... 806